Aerie Pharmaceuticals, Inc. (AERI)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 15.16 |
| Open | 15.14 |
| Bid | 15.11 x 3100 |
| Ask | 15.20 x 4000 |
| Day's range | 15.14 - 15.24 |
| 52-week range | 4.81 - 15.37 |
| Volume | |
| Avg. volume | 1,524,967 |
| Market cap | 751.073M |
| Beta (5Y monthly) | -0.07 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.47 |
| Earnings date | 02 Nov 2022 - 07 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 15.32 |
- Zacks
Catalyst Pharma's (CPRX) sNDA for Firdapse Approved by the FDA
Catalyst Pharmaceuticals (CPRX) announces FDA approval of its sNDA for Firdapse to include pediatric patients for treating Lambert-Eaton myasthenic syndrome.
- Zacks
KemPharm (KMPH) Up On Positive Data From Sleep Disorder Study
KemPharm (KMPH) reports positive top line from a study evaluating serdexmethylphenidate (SDX) for cardiovascular safety to progress the development of its prodrug KP1077.
- Zacks
Is Aerie Pharmaceuticals (AERI) Stock Outpacing Its Medical Peers This Year?
Here is how Aerie Pharmaceuticals (AERI) and Hanger (HNGR) have performed compared to their sector so far this year.
© 2022 Yahoo. All rights reserved.
